002620 — Jeil Pharma Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩122bn
- KR₩332bn
- KR₩780bn
Annual cashflow statement for Jeil Pharma Holdings, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 14,941 | -12,870 | -83,145 | -13,241 | -66,391 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 8,940 | 10,760 | 77,504 | 28,548 | 59,389 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -56,203 | 6,530 | -26,066 | -32,279 | -2,555 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -23,671 | 13,403 | -20,802 | -4,416 | 4,542 |
| Capital Expenditures | -10,267 | -23,736 | -21,410 | -9,837 | -6,863 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 8,661 | 31,061 | 3,846 | -3,588 | 9,137 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,606 | 7,325 | -17,564 | -13,425 | 2,274 |
| Financing Cash Flow Items | -315 | -810 | — | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 24,894 | -12,238 | 44,914 | 20,616 | 14,217 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1,054 | 8,397 | 6,179 | 2,279 | 22,782 |